Currently Viewing:
Currently Reading
ADA 2018 Standards Address Drugs With CV Benefits, Hold Firm on Blood Pressure
December 10, 2017 – Mary Caffrey
UC San Diego Researchers Receive $600,000 Grant to Test PI3Ky Inhibitor
December 08, 2017 – Kelly Davio
5 Approvals and Updates From the FDA This Week
December 08, 2017 – Jaime Rosenberg
AJMC® in the Press, December 8, 2017
December 08, 2017 – AJMC Staff
What We're Reading: Drug Imports; Insurers See ACA Profits; Alzheimer's Forecast
December 08, 2017 – AJMC Staff
This Week in Managed Care: December 8, 2017
December 08, 2017
Company Says It Will Seek FDA Approval for Video Game to Treat ADHD
December 07, 2017 – Allison Inserro
After Years of Research Into Dissatisfaction With Quality Measures, Is CMS Listening?
December 07, 2017 – Allison Inserro
Ribociclib Plus Oral Endocrine Partner Shows Efficacy in Women With HR+/HER2- Breast Cancer
December 07, 2017 – Jaime Rosenberg

Study: Improvements Needed in Post-Acute Care Interventions for AECOPD

Alison Rodriguez
Hospitalization for patients with acute exacerbated chronic obstructive pulmonary disease (AECOPD) create a significant burden for the patients and healthcare system. Improvements to key elements of care are necessary in order to relieve these major burdens, according to new research published in International Journal of Chronic Obstructive Pulmonary Disease.

The study attempted to measure the implementation rates of acute and post-acute hospital care interventions for AECOPD through a 24-month retrospective medical chart review of consecutive AECOPD hospitalization cases at 3 public hospitals in Switzerland. The researchers identified AECOPD hospitalization by applying an electronic search to physicians’ documentations, to only include those who were hospitalized in the medical or respiratory ward at each hospital.

“In-hospital management of AECOPD is focused on the acute stage with demand-responsive measures, ie, pharmacotherapy, oxygen therapy and, if necessary, noninvasive ventilation or invasive mechanical ventilation,” the authors explained. “However, it must be acknowledged that exacerbations leading to hospitalizations are an acute and severe worsening of a preexisting chronic disease and harbor a high risk of recurrence.”

Of the 263 hospitalizations that were analyzed, the median length of stay was 9 days and 32% of hospitalizations consisted of patients with previous AECOPD hospitalizations. In addition, the implementation rates of 4 acute care interventions were greater than 75%, compared to less than 25% for the implementation rates of 5 post-acute care interventions.

The acute care implementation rate was 56% for the appropriate administration of antibiotics, with over-prescription in 38% of the cases and under-prescription in 6%. The interventions for smoking cessation were present in 47% of the currently smoking patients and the referral for rehabilitation was suggested in 24% of the cases.

“These findings of potential shortcomings in hospital care, however, require careful interpretation. The majority of the post-acute care interventions are not linked to clearly defined and traceable technical processes as acute care measures are (eg, radiologic imaging),” the authors wrote. “In some cases, self-management interventions and also smoking cessation interventions, for example, might have been delivered to patients without according documentation in the medical chart or in the discharge letter.”

The study demonstrated the need for improvements in post-acute care interventions for AECOPD. The researchers suggested better communication and documentation practices in order to improve patient care.

Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!